Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients...

Por Hoffknecht, Petra, Tufman, Amanda, Wehler, Thomas, Pelzer, Theo, Wiewrodt, Rainer, Schütz, Martin, Serke, Monika, Stöhlmacher-Williams, Jan, Märten, Angela, Maria Huber, Rudolf, Dickgreber, Nicolas J.
Publicado no J Thorac Oncol (2015)

Soft Tissue Sarcomas of the Thoracic Wall: More Prone to Higher Mortality, and Local Recurrence—A Single Institution Long-Term Follow-up Study

Por Soerensen, Tine Rytter, Raedkjaer, Mathias, Jørgensen, Peter Holmberg, Hoejsgaard, Anette, Safwat, Akmal, Baad-Hansen, Thomas
Publicado no Int J Surg Oncol (2019)

Feasibility and safety of robot-assisted thoracic surgery for lung lobectomy in patients with non-small cell lung cancer: a systematic review and meta-analysis

Por Wei, Shiyou, Chen, Minghao, Chen, Nan, Liu, Lunxu
Publicado no World J Surg Oncol (2017)

Obatoclax Mesylate, a Pan–Bcl-2 Inhibitor, in Combination with Docetaxel in a Phase 1/2 Trial in Relapsed Non–Small-Cell Lung Cancer

Por Chiappori, Alberto, Williams, Charles, Northfelt, Donald W., Adams, John W., Malik, Shakun, Edelman, Martin J., Rosen, Peter, Van Echo, David A., Berger, Mark S., Haura, Eric B.
Publicado no J Thorac Oncol (2014)

Intercalated Erlotinib-Docetaxel Dosing Schedules Designed to Achieve Pharmacodynamic Separation: Results of a Phase I/II Trial

Por Sangha, Randeep, Davies, Angela M., Lara, Primo N., Mack, Philip C., Beckett, Laurel A., Hesketh, Paul J., Lau, Derick, Li, Tianhong, Perkins, Natasha, Gandara, David R.
Publicado em 2011

SWOG 0709: Randomized Phase II Trial of Erlotinib vs. Erlotinib plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as...

Por Lara, Primo N., Moon, James, Hesketh, Paul J., Redman, Mary W., Williamson, Stephen K., Akerley, Wallace L., Hirsch, Fred R., Mack, Philip C., Gandara, David R.
Publicado no J Thorac Oncol (2015)

Implications for high-precision dose radiation therapy planning or limited surgical resection after percutaneous computed tomography-guided lung nodule biopsy using a tract sealant

Por de Groot, Patricia M., Shroff, Girish S., Ahrar, Judy, Sabloff, Bradley S., Gladish, Garret M., Moran, Cesar, Gupta, Sanjay, Gladish, Gregory W., Chang, Joe Y., Erasmus, Jeremy J.
Publicado no Adv Radiat Oncol (2017)

From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of...

Por Couraud, S., Cortot, A. B., Greillier, L., Gounant, V., Mennecier, B., Girard, N., Besse, B., Brouchet, L., Castelnau, O., Frappé, P., Ferretti, G. R., Guittet, L., Khalil, A., Lefebure, P., Laurent, F., Liebart, S., Molinier, O., Quoix, E., Revel, M.-P., Stach, B., Souquet, P.-J., Thomas, P., Trédaniel, J., Lemarié, E., Zalcman, G., Barlési, F., Milleron, B.
Publicado em 2013

Clinicopathologic Features of NSCLC Diagnosed During Pregnancy or the Peripartum Period in the Era of Molecular Genotyping

Por Dagogo-Jack, Ibiayi, Gainor, Justin F., Porter, Rebecca L., Schultz, Katherine R., Solomon, Benjamin J., Stevens, Sara, Azzoli, Christopher G., Sequist, Lecia V., Lennes, Inga T., Shaw, Alice T.
Publicado no J Thorac Oncol (2016)

Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor epidermal growth factor receptor (EGFR) mutations

Por Janjigian, Yelena Y., Park, Bernard J., Zakowski, Maureen F., Ladanyi, Marc, Pao, William, D’Angelo, Sandra P., Kris, Mark G., Shen, Ronglai, Zheng, Junting, Azzoli, Christopher G.
Publicado em 2011

Association of Patient-Provider Communication Domains with Lung Cancer Treatment

Por Lin, Jenny J., Lake, Jessica, Wall, Melanie M., Berman, Andrew R., Salazar-Schicchi, John, Powell, Charles, Keller, Steven M., Halm, Ethan A., Leventhal, Howard, Wisnivesky, Juan P.
Publicado em 2014

Treatment with HIF-1α Antagonist PX-478 Inhibits Progression and Spread of Orthotopic Human Small Cell Lung Cancer and Lung Adenocarcinoma in Mice

Por Jacoby, Jörg J., Erez, Baruch, Korshunova, Maria V., Williams, Ryan R., Furutani, Kazuhisa, Takahashi, Osamu, Kirkpatrick, Lynn, Lippman, Scott M., Powis, Garth, O’Reilly, Michael S., Herbst, Roy S.
Publicado em 2010

Correlation Between Polymorphisms of the Reduced Folate Carrier Gene (SLC19A1) and Survival After Pemetrexed-Based Therapy in Non-small Cell Lung Cancer: A North Central Cancer Tre...

Por Adjei, Araba A., Salavaggione, Oreste E., Mandrekar, Sumithra J., Dy, Grace K., Allen Ziegler, Katie L., Endo, Chiaki, Molina, Julian R., Schild, Steven E., Adjei, Alex A.
Publicado no J Thorac Oncol (2010)

Absence of a Relationship between Tumor (18)F-fluorodeoxyglucose Standardized Uptake Value and Survival in Patients Treated with Definitive Radiotherapy for Non–Small-Cell Lung Can...

Por Lin, Ming-Yin, Wu, Muzo, Brennan, Sinead, Campeau, Marie-Pierre, Binns, David Sidney, MacManus, Michael, Solomon, Benjamin, Hicks, Rodney J., Fisher, Richard John, Ball, David Lee
Publicado em 2014

LONG-TERMS RESULTS OF A TRIAL OF CONCURRENT CHEMOTHERAPY AND ESCALATING DOSES OF RADIATION FOR UNRESECTABLE NON–SMALL CELL LUNG CANCER: NCCTG N0028 (ALLIANCE)

Por Schild, Steven E., Hillman, Shauna L., Tan, Angelina D., Ross, Helen J., McGinnis, William L., Garces, Yolanda A., Graham, David L., Adjei, Alex A., Jett, James R.
Publicado no J Thorac Oncol (2017)

Pretreatment Quality of Life Is an Independent Prognostic Factor for Overall Survival in Patients with Advanced Stage Non-small Cell Lung Cancer

Por Qi, Yingwei, Schild, Steven E., Mandrekar, Sumithra J., Tan, Angelina D., Krook, James E., Rowland, Kendrith M., Garces, Yolanda I., Soori, Gamini S., Adjei, Alex A., Sloan, Jeff A.
Publicado em 2009

The introduction of systematic genomic testing for patients with non-small cell lung cancer

Por Heon, Stephanie, Ortiz, Taylor M., Joshi, Victoria A., Butaney, Mohit, Jackman, David M., Kwiatkowski, David J., Yeap, Beow Y., Jänne, Pasi A., Lindeman, Neal I., Johnson, Bruce E.
Publicado em 2012

Clinical Characteristics and Course of 63 patients with BRAF Mutant Lung Cancers

Por Litvak, A.M., Paik, P.K., Woo, K. M., Sima, C. S., Hellmann, M. D., Arcila, M.E., Ladanyi, M., Rudin, C. M., Kris, M. G., Riely, G. J.
Publicado no J Thorac Oncol (2014)

EGFR gene copy number by FISH may predict outcome of necitumumab in squamous lung carcinomas: analysis from the SQUIRE study.

Por Genova, Carlo, Socinski, Mark A., Hozak, Rebecca R., Mi, Gu, Kurek, Raffael, Shahidi, Javad, Paz-Ares, Luis, Thatcher, Nick, Rivard, Christopher J., Varella- Garcia, Marileila, Hirsch, Fred R.
Publicado no J Thorac Oncol (2017)

Brief Report: Increased Hepatotoxicity Associated with Sequential Immune Checkpoint Inhibitor and Crizotinib Therapy in Patients with Non-Small-Cell Lung Cancer

Por Lin, Jessica J., Chin, Emily, Yeap, Beow Y., Ferris, Lorin A., Kamesan, Vashine, Lennes, Inga T., Sequist, Lecia V., Heist, Rebecca S., Mino-Kenudson, Mari, Gainor, Justin F., Shaw, Alice T.
Publicado no J Thorac Oncol (2018)